Press Release Ractigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS 6 August 2026
Press Release Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update 6 August 2026
Press Release Charter Announces Results Of Early Tenders In Debt Exchange Offers And Amendment And Upsize of Debt Exchange Offers 6 August 2026
Press Release LUX Infusion Acquires Infuse IQ, Expanding Its National Ambulatory Infusion Footprint 6 August 2026
Press Release Verified Clinical Trials Partners with WindRose Health Investors to Accelerate Growth and Welcomes Howard Miller as Chief Executive Officer 6 August 2026
Press Release Australia’s Department of Foreign Affairs and Trade Extends Partnership with Cambridge Global Advisors to Build Cyber Capacity Among Women in the Pacific 6 August 2026
